Precision dosing of imatinib and tamoxife
Not Applicable
- Conditions
- Health Condition 1: C50-C50- Malignant neoplasms of breastHealth Condition 2: D72- Other disorders of white blood cells
- Registration Number
- CTRI/2022/07/044424
- Lead Sponsor
- Manipal Academy of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed with chronic myeloid leukemia and breast cancer
Exclusion Criteria
Patients taking concomitant cancer medication
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method